Joseph Stanek

ORCID: 0000-0003-1630-2102
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • Childhood Cancer Survivors' Quality of Life
  • Hemoglobinopathies and Related Disorders
  • Iron Metabolism and Disorders
  • Neuroblastoma Research and Treatments
  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia research
  • Venous Thromboembolism Diagnosis and Management
  • Blood Coagulation and Thrombosis Mechanisms
  • Platelet Disorders and Treatments
  • Testicular diseases and treatments
  • Blood groups and transfusion
  • Brain Metastases and Treatment
  • Hemophilia Treatment and Research
  • Renal and related cancers
  • Central Venous Catheters and Hemodialysis
  • Neutropenia and Cancer Infections
  • Chromatin Remodeling and Cancer
  • Food Security and Health in Diverse Populations
  • Reproductive Health and Contraception
  • Ocular Oncology and Treatments
  • Sarcoma Diagnosis and Treatment
  • Adolescent and Pediatric Healthcare
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Acute Myeloid Leukemia Research

Nationwide Children's Hospital
2016-2025

The Ohio State University
2015-2025

Karolinska Institutet
2024

Centre Hospitalier Universitaire Sainte-Justine
2024

Université de Montréal
2024

Seattle Children's Hospital
2023

Seattle University
2023

University of Washington
2023

University of Toledo Medical Center
2021

Cancer Research And Biostatistics
2018-2019

OBJECTIVES In 2009, a large multicenter study demonstrated that the rate of pediatric venous thromboembolism (VTE) across US children’s hospitals had significantly increased from 2001 to 2007. The objective this was evaluate VTE 2008 2019 using similar methodology. METHODS A retrospective cohort Pediatric Health Information System (PHIS) database. Subjects birth <18 years admitted through who an ICD-9-CM or ICD-10-CM code for were included. Demographics, underling medical...

10.1542/peds.2021-054649 article EN PEDIATRICS 2022-02-14

ABSTRACT Background Neuroblastoma is the most common extracranial solid tumor in children, with about half of cases classified as high risk. Treatment varies by risk level, high‐risk patients undergoing aggressive multimodal therapy. While long‐term survival has improved, survivors face significant risks late treatment effects, including adrenal insufficiency. This study investigates incidence insufficiency among neuroblastoma varying disease Procedure retrospective cohort at a single...

10.1002/pbc.31543 article EN cc-by-nc-nd Pediatric Blood & Cancer 2025-01-21

Oncolytic virotherapy is an effective immunotherapeutic approach for cancer treatment via a multistep process including direct tumor cell lysis, induction of cytotoxic or apoptosis-sensitizing cytokines and promotion antitumor T responses. Solid tumors limit the effectiveness immunotherapeutics in diverse ways such as secretion immunosuppressive expression immune inhibitory ligands to inhibit function. Blocking programmed death protein (PD)-1 signaling, which mediates suppression engagement...

10.1038/s41598-017-02503-8 article EN cc-by Scientific Reports 2017-05-18

Menstruating women, with or without underlying bleeding disorders, are at increased risk for developing iron deficiency-related fatigue, even in the absence of anemia. Oral therapy has limitations which include poor absorption and non-adherence due to gastrointestinal side effects. We performed a prospective clinical trial post-menarchal adolescent females iron-deficiency mild anemia fatigue who received standardized regimen intravenous sucrose. The baseline mean (SD) hemoglobin was 11.96 g...

10.1002/ajh.24461 article EN American Journal of Hematology 2016-06-28

Abstract Patients with sickle cell disease (SCD) are predisposed to a hypercoagulable state. Despite the increased risk of venous thromboembolism in SCD population, there is limited evidence available guide thromboprophylaxis (TP) practices these patients. This study aimed assess use pharmacologic and nonpharmacologic TP adolescent patients using Pediatric Health Information System (PHIS). We hypothesized that was increasingly used hospitalized SCD. The included aged 13 21 years, admitted...

10.1182/bloodadvances.2022007802 article EN cc-by-nc-nd Blood Advances 2023-04-27

Key Points Adults with SCD have an increased incidence of VTE, but similar data in children are lacking. In this 7-year, multicenter retrospective study, 1.7% developed VTE.

10.1182/bloodadvances.2017012336 article EN cc-by-nc-nd Blood Advances 2018-02-05

United States studies documenting time interval from symptom onset to definitive diagnosis for childhood central nervous system (CNS) tumors are more than a quarter-century old. The purpose of this study is establish an accurate and contemporary Ohio baseline the diagnostic children with newly diagnosed CNS tumors.Medical records were retrospectively reviewed 301 January 2004 August 2015 at Nationwide Children's Hospital. We obtained comprehensive data on 171 patients (56.8%). Records age,...

10.1093/nop/npy002 article EN Neuro-Oncology Practice 2018-03-09

Background: Needles are frequently required for routine medical procedures. Children with severe hemophilia require intensive intravenous (IV) therapy to treat and prevent life-threatening bleeding undergo hundreds of IV Fear needle-related procedures may lead avoidance future health care poor clinical outcomes. Virtual reality (VR) is a promising distraction technique during procedures, but barriers commercially available VR platforms pediatric purposes have prevented widespread use....

10.2196/10902 article EN cc-by JMIR Serious Games 2018-10-18

To develop an improved interictal electroencephalogram (EEG) grading scale for children with infantile spasms founded on elements adequate inter-rater reliability (IRR) to justify its further study clinical and research purposes.Three blinded reviewers assessed five-minute sleep epochs in 93 EEGs from 62 (31 consecutive controls, 31 [pretreatment posttreatment studies]) using a longitudinal bipolar montage. We determined the IRR of background amplitude, epileptiform discharges, >3 spike foci...

10.1016/j.eplepsyres.2021.106631 article EN cc-by-nc-nd Epilepsy Research 2021-04-02

Anti-GD2 immunotherapy has improved outcomes for children with high-risk neuroblastoma (HRNBL). Dinutuximab promotes complement-mediated reaction against disialoganglioside GD2, which is expressed in peripheral nerves and over-expressed neuroblastoma. associated ≥grade 3 neuropathic pain. Targeting GD2 stimulates the NMDA receptor, makes ketamine useful treatment of The objective this retrospective study to describe use pain uncontrolled by opioids, ketamine's impact on total opioid usage...

10.2147/jpr.s487724 article EN cc-by-nc Journal of Pain Research 2025-01-01

ABSTRACT Background Treatments for adolescent and young adult (AYA) patients with mature B‐cell lymphomas (MBCL) differ between versus pediatric centers, data are scarce regarding comparative toxicities outcomes. Procedures We identified AYA (age 12–39) MBCL seen 2011 2021 at an (AC) (PC) tertiary cancer center. Data baseline characteristics, adverse events, long‐term outcomes were collected. Results A total of 173 identified, 20 in the PC 153 AC. During treatment, more unplanned...

10.1002/pbc.31664 article EN Pediatric Blood & Cancer 2025-03-22

ABSTRACT It is unclear if adolescents with sickle cell disease (SCD) are screened for depression, since primary care provider (PCP) visits decline age and socioeconomic disadvantage may impact receipt of care. This 1‐year study identified 97% SCD at Nationwide Children's Hospital (NCH) had a PCP. Among those an NCH PCP ( n = 55), 40% saw their 33% were depression. Socioeconomic was not associated depression screening p 0.55) or 0.22). While often have PCPs, interventions to increase...

10.1002/pbc.31655 article EN cc-by-nc Pediatric Blood & Cancer 2025-03-28

ABSTRACT Background Sickle cell disease (SCD) is a chronic illness accounting for 134,000 hospital admissions annually. Youth with SCD and youth autism spectrum disorder (ASD) experience health disparities, yet the hospitalization outcomes of these have not been assessed. This study aimed to (i) determine prevalence ASD selected neurodevelopmental disabilities (NDD) among hospitalized (ii) compare in NDD SCD. Procedure ICD‐10 diagnosis codes were used identify admitted (2–18 year olds) SCD,...

10.1002/pbc.31725 article EN Pediatric Blood & Cancer 2025-04-14

To design and test a metric that reflects the overall quality safety performance of our blood marrow transplant program (BMT) use this to enhance care provided patients. The BMT index (BMTI) aggregates events missed opportunities for best practices into composite score clinical program, irrespective type or patient outcome. We selected 13 domains divided them based on time in continuum. journey has 3 general spheres: (1) pretransplant, (2) admission, (3) posttransplant follow-up long-term...

10.1097/pq9.0000000000000811 article EN cc-by-nc-nd Pediatric Quality and Safety 2025-04-30

Abstract Background The combination of vincristine, irinotecan, and temozolomide (VIT) is often used to treat children adolescents with relapsed rhabdomyosarcoma (RMS); however, the outcome these patients has not been previously described. Procedures We sought determine response rate (RR) progression‐free survival (PFS) for RMS treated VIT by retrospective review at five tertiary care hospitals. Prior treatment irinotecan was permitted. Results Among 19 a median age 8 years (range 2–17...

10.1002/pbc.26728 article EN Pediatric Blood & Cancer 2017-07-27

Objective The risk of thrombosis is increased in patients with systemic lupus erythematosus (SLE). Few studies have assessed factors associated within the pediatric SLE (pSLE) population. We sought to better characterize these pSLE using Childhood Arthritis & Rheumatology Research Alliance (CARRA) registry. Methods Within CARRA registry, a history were compared those without. Univariate logistic regression was used calculate odds ratios. A multivariable model conducted that included...

10.1177/0961203316638164 article EN Lupus 2016-03-14
Coming Soon ...